Drug development and safety Flashcards
First 4 steps in the process of drug development
- Isolate or synthesize a new drug
- Determine chemical/pharmaceutical properties of the drug
- Determine the kinetics/dynamics
- Test animals for toxicity (acute, subacute, chronic) and teratogenesis, mutagenesis, and carcinogenesis
Second 3 steps in the process of drug development
- Outline properties of the drug
- Report results of studies
- Propose clinical studies
What does IND stand for
Investigational new drug
What are the steps during the IND application phase of drug development
- outlining properties,
2. report results of case studies, 3. propose clinical studies
What are the steps in the discovery and characterization phase
- Isolate/synthesize new drug
2. Determine chemical/pharm properties of drug
What are the steps during the experimental studies phase of drug development
- Determine kinetics/dynamics of a drug
2. Test animals for toxicity and mutations
What are the steps during the clinical studies phase
Phase 1
Phase 2
Phase 3
What happens during phase 1
Gathering data on drug safety and kinetics in HEALTHY VOLUNTEERS
What happens during phase 2
Gathering data on efficacy, safety, proper dosage in a SMALL group of pts
What happens during phase 3
Obtain statistical evidence of drug safety and efficacy. LARGE group of patients
What are the steps during submission of NDA
- Outline the properties of the drug
- Report results of all experiments and clinical trials
- Propose labeling of drug and clinical indications (for use)
What does NDA stand for
New drug approval
What are the final steps (2) in the drug development process
- NDA approval
2. Postmarketing surveillance
What is the difference between IND and NDA
IND is investigational new drug and it is the early stages of drug (before clinical trials). Where as NDA is the actual approval of the new drug for market
What happens after experimental studies
IND application